Kristen Bauer is the Director of Trading and Corporate Compliance at Aramco Trading Americas LLC (“ATA”). Since joining the company in June of 2016, she has been instrumental in aligning the company’s Trading Compliance obligations with its business activities. In 2021, Kristen’s role expanded to include managing the Credit and KYC teams in addition to the Trading Compliance Team, which allowed her to build upon her leadership skills. In 2023, the company split out its trading activity from the assets. With this move, Kristen is now responsible for Trading Compliance as well as setting up ATA’s Corporate Compliance program. Kristen leads with integrity and is fully committed to strong ethics and compliance principles. She is at the forefront of protecting ATA and building the company’s reputation in the industry while simultaneously keeping good business acumen. Prior to assuming her current role at ATA, Kristen was a Manager in Deloitte’s Regulatory Compliance practice where she worked with various companies to construct robust compliance programs highlighting and implementing best practices. Her experience as a Director at the Chicago Mercantile Exchange as well as various roles in trading, scheduling, credit, and settlements at multiple asset management companies has led to her expertise in Trading and Corporate Compliance. Kristen received her B.A. from the University of Kentucky.

Stan is the Head of Americas Supervision at Citadel Securities covering trading, technology, and risk management, and an Adjunct Professor of Law at Fordham University School of Law teaching Trading, Risk Management & Market Structure Regulation. Stan previously worked at Marshall Wace architecting the US compliance program and scaling globally to EU and APAC. Prior to that he worked at Knight Capital Group focusing on algorithmic trading, market structure, and surveillance. He holds a J.D. in Law from Fordham University School of Law where he was an Associate Editor on the Journal of Corporate & Financial Law, and additionally holds an M.Eng. in Engineering Management, M.S. in Pharmaceutical Manufacturing Engineering, and M.A. in Technology, Policy & Ethics from Stevens Institute of Technology. When not lecturing on regulatory trends, product development, and technology, Stan can be found on the tennis courts.

Robb Giddings is Deputy General Counsel of QOL Medical, a specialty pharmaceutical manufacturer, where he has led the company’s legal, compliance, and privacy functions for the past 4+ years. Prior to QOL, he held various in-house and private practice roles working with FDA-regulated companies helping them to grow their businesses and expand their operations efficiently and compliantly.

Tom joined Fairwords in 2021 as Chief Executive Officer, where he leads the communications protection software company’s strategy, P&L, and growth initiatives. Tom has a strong record of driving growth and exit strategies for rapid-growth B2B technology organizations like LRN and S&P CapitalIQ. In his most recent role as Chief Operating Officer for LRN, a leading provider of ethics and compliance technology-enabled education and solutions, he took full command of the P&L and led the 250-person multinational company to a turnaround that resulted in the company’s successful exit. In his earlier roles, Tom was part of the executive teams that took responsibility for revenue targets over $1B+, led teams with more than 4,500 employees, and managed legal and business strategies and operations related to IPOs and sales to corporations including Standard and Poors. Tom’s passion for creating solutions that foster great cultures and compliance was originally inspired by his work at Columbia University’s School of Law, where he earned his Juris Doctorate degree in 1994.